-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2024.
- Akero Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.05 USD/shares, a 47.9% decline year-over-year.
- Akero Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -3.79 USD/shares, a 64.8% decline year-over-year.
- Akero Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.89 USD/shares, a 0.7% decline from 2022.
- Akero Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.87 USD/shares, a 0.69% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)